Companies: 10,795·Total market cap: $144.5T
Beam Therapeutics Inc.

Beam Therapeutics Inc.

BEAMNASDAQHealthcare● Active
$29.40
$-3.44(-10.48%)
Market Cap$3.0B
P/E Ratio—
52W High$36.44
52W Low$15.6
SEC Filings

Beam Therapeutics Inc. (BEAM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001745999 · BEAM · NASDAQ · as of Jun 8, 2026

Filing snapshot

494
Total Filings
4
Latest Form
2026-06-05
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001745999 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-24
Fiscal Year End
Feb 24, 2026
Accession No.
0001193125-26-065194
Primary Document
beam-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001745999 · Accession 0001193125-26-065194

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
ARSARS
ARS
2026-04-17
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-17
View
DEF 14AProxy Statement
DEF 14A
2026-04-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
8-KCurrent Report
8-K
2026-03-05
View
S-8Employee Stock Plan Registration
S-8
2026-02-24
View
10-KAnnual Report
10-K
2026-02-24
View
8-KCurrent Report
8-K
2026-02-24
View
8-KCurrent Report
8-K
2026-02-12
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-09
View
8-KCurrent Report
8-K
2026-02-05
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-05
View
Showing 1–15 of 249 filingsForm 4 / 144 hidden· 494 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001745999  |  Exchange: NASDAQ · Healthcare

Beam Therapeutics Inc. (NASDAQ: BEAM) has submitted 494 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001745999, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Beam Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Beam Therapeutics Inc. 10-K was filed on 2026-02-24 for fiscal year ending 2026. Historical BEAM 10-K annual reports are available from 2018 through 2026.

Investors researching Beam Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
IBRX SEC Filings →COGT SEC Filings →DNLI SEC Filings →IDYA SEC Filings →RCUS SEC Filings →ETNB SEC Filings →GLPG SEC Filings →AGIO SEC Filings →
→ BEAM Financials→ BEAM Earnings→ BEAM Insider Trades

Frequently Asked Questions

BEAM SEC Filings · 8 questions

Beam Therapeutics Inc. (BEAM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 494 filings and access original documents at no cost. Beam Therapeutics Inc.'s CIK is 0001745999.

BEAM SEC filingsBeam Therapeutics Inc. SEC documentsfind BEAM 10-K